| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/11/2007 | CN1309374C Improved rapidly disintegratable multiparticulate tablet |
| 04/11/2007 | CN1309373C Granular preparation for treating cancer and its quality control method |
| 04/11/2007 | CN1309372C Preparation of granular powder for treating hepatitis and quality control method |
| 04/11/2007 | CN1309371C Granular preparation for treating deficiency of vital energy and anaemia and its quality control method |
| 04/11/2007 | CN1309370C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 04/11/2007 | CN1309369C Maluoning powder injection for injection and its preparing method |
| 04/11/2007 | CN1309368C Chinese traditional medicine for curing cough |
| 04/11/2007 | CN1309367C Preparation of Chinese traditional medicine for curing gallstone and preparation method thereof |
| 04/11/2007 | CN1309322C Composite nutrient food and processing method thereof |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202282 Microemulsions for selective molecular separation |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202231 β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/10/2007 | US7202230 Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity |
| 04/10/2007 | US7202227 Multifunctional molecular complexes for gene transfer to cells |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202207 Infection therapy; binding of mannan lecithin to protein |
| 04/10/2007 | US7202087 exploits the advantageous properties of lipids as pharmaceutical carriers in regard of gastroinstestinal uptake and/or sustained release and/or convenience and/or economy |
| 04/10/2007 | US7202080 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 04/10/2007 | US7202078 Composition intended for the preservation of infectious recombinant adenoviruses |
| 04/10/2007 | US7202065 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 04/10/2007 | US7201930 Licorice root extract oral patch for treating canker sores |
| 04/10/2007 | US7201925 Treatment of ungual and subungual diseases |
| 04/10/2007 | US7201923 Nutraceuticals, drugs, contains an active, sensitive encapsulant, such as a live microorganism or an enzyme dissolved or dispersed in a liquid plasticizer is admixed with a plasticizable matrix material; shelf-stable, controlled release, discrete, solid particles from a liquid encapsulant |
| 04/10/2007 | US7201922 Codried granules of lactose and starch with an active substance |
| 04/10/2007 | US7201921 A filling formualtion for soft capsule dosage containing loratadine and derivative, a mixture of mono and diglyceride of medium chain fatty acids, povidone and polyoxyethylene sorbitan fatty ester; capsule material is carrageenan |
| 04/10/2007 | US7201920 Analgesically effective amount of opioid analgesic is combined with polymer to form a matrix |
| 04/10/2007 | US7201919 Mixture for transdermal delivery of low and high molecular weight compounds |
| 04/10/2007 | US7201914 May contain a viricide, a bactericide or bacteriostate, and/or an antiinflammatory agent; uses include control of microbial growth on gloved hands |
| 04/10/2007 | US7201913 Oral formulations for anti-tumor compounds |
| 04/10/2007 | US7201898 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/10/2007 | US7201746 Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve |
| 04/10/2007 | US7201734 Apparatus for drug delivery in association with medical or surgical procedures |
| 04/10/2007 | CA2403869C Method for treating dry eye |
| 04/10/2007 | CA2402637C Valve for osmotic devices |
| 04/10/2007 | CA2333985C Testosterone derivative |
| 04/10/2007 | CA2321969C Process for the production of encased, spherical granular grains |
| 04/10/2007 | CA2315293C Progesterone tablet and preparation method |
| 04/10/2007 | CA2314848C Process for preparing beadlets containing fat-soluble substances |
| 04/10/2007 | CA2302554C Oil in water emulsions containing saponins |
| 04/10/2007 | CA2300281C Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 04/10/2007 | CA2297924C Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 04/10/2007 | CA2278684C Thimerosal-free preservatives for vaccines |
| 04/10/2007 | CA2270220C Adhesives with low level of residual monomers and process for manufacturing same |
| 04/10/2007 | CA2251944C Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 04/10/2007 | CA2202300C Active agent transport systems |
| 04/10/2007 | CA2202170C Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/10/2007 | CA2200061C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 04/10/2007 | CA2198240C Topical ketoconazole emulsions |
| 04/10/2007 | CA2194407C Gel formulation |
| 04/10/2007 | CA2194168C Improved bioadhesive pharmaceutical delivery system |
| 04/10/2007 | CA2189424C Non-steroidal anti-inflammatory ophthalmic suspensions |
| 04/10/2007 | CA2187748C Fusogenic liposomes and methods of making and using same |
| 04/10/2007 | CA2179041C Biphasic capsule formulation |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2176145C Biocompatible ocular implants |
| 04/10/2007 | CA2168671C A method for high loading of vesicles with biopolymeric substances |
| 04/10/2007 | CA2167970C Transdermal drug delivery device containing a desiccant |
| 04/10/2007 | CA2138351C Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 04/10/2007 | CA2107335C Device for dispensing a medicament |
| 04/07/2007 | CA2562980A1 Method for forming contact lenses comprising therapeutic agents |
| 04/05/2007 | WO2007038802A2 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
| 04/05/2007 | WO2007038627A2 Stabilized antimicrobial compositions and related methods of preparation |
| 04/05/2007 | WO2007038549A1 Treatment of inflammation and vascular abnormalities of the eye |
| 04/05/2007 | WO2007038524A2 Cocrystallization methods |
| 04/05/2007 | WO2007038386A2 Method for enhancing immune responses in mammals |
| 04/05/2007 | WO2007038329A2 A patch for treating symptoms of a skin abscess |
| 04/05/2007 | WO2007038325A2 Indanylamines and their use for local anesthesia and chronic pain |
| 04/05/2007 | WO2007038274A2 Effervescent oral care compositions and methods of use |
| 04/05/2007 | WO2007038252A2 Methods and compositions for treating skin lines and wrinkles and improving skin quality |
| 04/05/2007 | WO2007038126A1 In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof |
| 04/05/2007 | WO2007037981A2 Stable microemulsion concentrate for delivery of a bioactive ingredient in an aqueous medium |
| 04/05/2007 | WO2007037790A2 Modified release famciclovir compositions |
| 04/05/2007 | WO2007037607A1 Hfsh aqueous formulation |
| 04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
| 04/05/2007 | WO2007037476A1 Iontophoresis apparatus capable of controlling dose and timing of administration of sleep inducer and analeptic agent |
| 04/05/2007 | WO2007037444A1 Vector for delivering target substance into nucleus or cell |
| 04/05/2007 | WO2007037330A1 Method for production of quinolone-containing lyophilized preparation |
| 04/05/2007 | WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon |
| 04/05/2007 | WO2007037259A1 Pulse preparation having improved disintegration properties in vivo |
| 04/05/2007 | WO2007037249A1 Cellooligosaccharide-containing composition |
| 04/05/2007 | WO2007037158A1 Capsule-type drug release device and capsule-type drug release system |
| 04/05/2007 | WO2007036947A1 Delayed release anti-malarial composition |
| 04/05/2007 | WO2007036946A1 Compositions for enhanced absorption of biologically active agents |
| 04/05/2007 | WO2007036682A1 Coated microspheres |
| 04/05/2007 | WO2007036671A2 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 04/05/2007 | WO2007036632A1 Orodispersible tablets of bitter active principles |
| 04/05/2007 | WO2007036376A2 Skincare products |
| 04/05/2007 | WO2007036278A2 Method for stabilising pharmaceutical administration forms that contain micro-organisms |
| 04/05/2007 | WO2007036107A1 An exterior-applied formulation and its preparation methods and uses |
| 04/05/2007 | WO2007036060A1 Method for the attachment of nanoparticles to substrate particles |
| 04/05/2007 | WO2007036029A1 Aerosol powder formulation comprising sieved lactose |
| 04/05/2007 | WO2007017513A3 Formulations for 7-(t-butoxy)iminomethyl camptothecin |
| 04/05/2007 | WO2007016287A9 Pdt treatment method for cellulites and cosmetic use |
| 04/05/2007 | WO2007013975A3 Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications |
| 04/05/2007 | WO2007012478A3 Encapsulation of lipid-based formulations in enteric polymers |
| 04/05/2007 | WO2007010430A3 Pharmaceutical composition for treating xerostomia |
| 04/05/2007 | WO2007010400A3 Gastroretentive formulations and manufacturing process thereof |
| 04/05/2007 | WO2007010400A2 Gastroretentive formulations and manufacturing process thereof |
| 04/05/2007 | WO2007010396A3 Dry state coating process |